Latest News and Press Releases
Want to stay updated on the latest news?
-
Bicycle Health Expands Leadership Team to Increase Access to Evidence-Based Opioid Use Disorder Care
ATLANTA, May 05, 2026 (GLOBE NEWSWIRE) -- Bicycle Health, the nation’s leading technology-enabled virtual medical group delivering evidence-based treatment for opioid use disorder (OUD), today...
-
LOS ANGELES, March 13, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Mattel, Inc., (“Mattel" or the "Company") (NASDAQ:MAT) investors that the firm has initiated an investigation into...
-
LOS ANGELES, March 13, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Mattel, Inc., (“Mattel" or the "Company") (NASDAQ:MAT) investors that the firm has initiated an investigation into...
-
MAT Investors Have Opportunity to Join Mattel, Inc. Fraud Investigation with the Schall Law Firm
-
AppleGate Recovery unveils a refreshed brand and logo, aligning with BayMark Health Services to highlight unified, compassionate, and accessible care.
-
WEST PALM BEACH, FLORIDA, June 16, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (“FOXO” or the “Company”) today announced that it formed a new, wholly-owned subsidiary...
-
Minovia Therapeutics Announces FDA Clearance of Second IND Application, for a Phase II Clinical Trial of Lead Product MNV-201 in Pearson Syndrome
-
MINNEAPOLIS, MN, Feb. 24, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (the “Company or FOXO”), announces that it has executed a non-binding acquisition agreement for two...
-
In response to Rhode Island’s ongoing overdose crisis, AdCare Rhode Island, is hosting a free community event on medication-assisted treatment (MAT).
-
MNV-201 is a mitochondrial cell therapy product composed of autologous hematopoietic stem cells enriched with allogeneic mitochondria In pre-clinical studies, MNV-201 demonstrated improved...